Characterization of cefotaxime resistant Escherichia coli isolated from broiler farms in Ecuador

PLoS One. 2019 Apr 5;14(4):e0207567. doi: 10.1371/journal.pone.0207567. eCollection 2019.

Abstract

Antimicrobial resistance (AR) is a worldwide concern. Up to a 160% increase in antibiotic usage in food animals is expected in Latin American countries. The poultry industry is an increasingly important segment of food production and contributor to AR. The objective of this study was to evaluate the prevalence, AR patterns and the characterization of relevant resistance genes in Extended Spectrum β-lactamases (ESBL) and AmpC-producing E. coli from large poultry farms in Ecuador. Sampling was performed from June 2013 to July 2014 in 6 slaughterhouses that slaughter broilers from 115 farms totaling 384 flocks. Each sample of collected caeca was streaked onto TBX agar supplemented with cefotaxime (3 mg/l). In total, 176 isolates were analyzed for AR patterns by the disk diffusion method and for blaCTX-M, blaTEM, blaCMY, blaSHV, blaKPC, and mcr-1 by PCR and sequencing. ESBL and AmpC E. coli were found in 362 flocks (94.3%) from 112 farms (97.4%). We found that 98.3% of the cefotaxime-resistant isolates were multi-resistant to antibiotics. Low resistance was observed for ertapenem and nitrofurantoin. The most prevalent ESBL genes were the ones belonging to the blaCTX-M group (90.9%), specifically the blaCTX-M-65, blaCTX-M-55 and blaCTX-M-3 alleles. Most of the AmpC strains presented the blaCMY-2 gene. Three isolates showed the mcr-1 gene. Poultry production systems represent a hotspot for AR in Ecuador, possibly mediated by the extensive use of antibiotics. Monitoring this sector in national and regional plans of AR surveillance should therefore be considered.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cefotaxime / pharmacology*
  • Chickens / microbiology*
  • Ecuador
  • Escherichia coli Infections* / genetics
  • Escherichia coli Infections* / microbiology
  • Escherichia coli Proteins / genetics*
  • Escherichia coli* / genetics
  • Escherichia coli* / isolation & purification
  • Escherichia coli* / pathogenicity
  • Poultry Diseases* / genetics
  • Poultry Diseases* / microbiology
  • beta-Lactam Resistance / genetics*

Substances

  • Escherichia coli Proteins
  • Cefotaxime

Grants and funding

This work was supported by Secretaría de Educación Superior Ciencia y Tecnología del Ecuador; Programa de Becas Convocatoria Abierta 2012 Segunda Fase; http://www.educacionsuperior.gob.ec; to CVB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.